Helen Ebral, PA to CVP, Digital Transformation at Novo Nordisk

Helen Ebral

PA to CVP, Digital Transformation at Novo Nordisk | Copenhagen, Capital Region of Denmark, Denmark

Profile last verified June 2026
Pharmaceuticals Verified Profile Copenhagen, Capital Region of Denmark, Denmark TalTech – Tallinn University of Technology
Verified

Personal Email

***@gmail.com

Personal • High Confidence

Phone Number

(**) *** *** 385

Denmark • Phone

Free account · No credit card · 5 profiles/month

Helen Ebral Socials
Helen Ebral Work Experience

PA to CVP, Digital Transformation at Novo Nordisk in October 2023 - Present

PA to Head of Digital Transformation Office at Novo Nordisk in December 2022 - October 2023

PA to Chief Digital Officer at Novo Nordisk in July 2021 - November 2022

See more See less

Personal Assistant to Group COO at ISS A/S in April 2021 - June 2021

Executive Assistant to Managing Director Nordics & to EVP Global Siemens Account at Atos in March 2017 - April 2021

Financial Assistant at Upper Two Capital in October 2015 - February 2017

Office Manager at Cloutex in December 2013 - June 2015

Helen Ebral Education

TalTech – Tallinn University of Technology, Master's degree, July 2026

Tallinn University, Master's degree, July 2026

Helen Ebral Skills
Digital Marketing Special Events Coordination Email Marketing Human Resources Events Coordination Office Administration Office Management Social Media Marketing New Business Development Management Consulting Public Relations Management Event Management Communication Microsoft Office Teamwork Virtual Teams Recruiting Onboarding Social Media Communications Project Management Internal Communications Administration Budgeting Interviewing Team Building
About Helen Ebral’s Current Company
Novo Nordisk

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Discover more about Novo Nordisk
Helen Ebral’s Colleagues
Tore Veum

Tore Veum

Norway

Global Director Frontline Excellence Rare Diseases, Novo Nordisk

Owner at Veum Consulting
(March 2015 – Present)

Naheel Korfiatis

Naheel Korfiatis

Dubai, United Arab Emirates

PMP® | Regulatory Affairs Project Lead (Business Area Middle East, Affrica & CIS) at Novo Nordisk

Regulatory Affairs Project Lead (Business Area Middle East, Africa &CIS) at Novo Nordisk
(January 2024 – Present)

Karleen Rush

Karleen Rush

Raleigh-Durham-Chapel Hill Area

Medical Science Liaison, Diabetes & Renal

Wine Rep at ONEHOPE Wine
(June 2021 – Present)

Gaetano Gati

Gaetano Gati

Rome, Latium, Italy

Public Affairs Manager presso Novo Nordisk

Public Affairs Manager at Novo Nordisk
(May 2022 – Present)

Diego Bacelic

Diego Bacelic

Toronto, Ontario, Canada

Obesity Market Access | Novo Nordisk Canada

Consultant at Global Market Access Solutions
(May 2026 – May 2026)

Anne Preskou

Anne Preskou

Copenhagen, Capital Region of Denmark, Denmark

Associate Director – Novo Nordisk

Student in Business Partner Operation Nordic (BPO) at IBM
(January 2006 – May 2026)

Search similar profiles
Frequently asked questions about Helen Ebral

What is Helen Ebral email address?

Email Helen Ebral at [email protected] and [email protected]. This email is the most updated Helen Ebral's email found in 2026.

How to contact Helen Ebral?

To contact Helen Ebral send an email to [email protected] or [email protected]. (updated on November 28, 2025)

What company does Helen Ebral work for?

Helen Ebral works for Novo Nordisk.

What is Helen Ebral's role at Novo Nordisk?

Helen Ebral is PA to CVP, Digital Transformation

What industry does Helen Ebral work in?

Helen Ebral works in the Pharmaceuticals industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free